Chemical activators of V1RD19 can engage in a variety of intracellular signaling pathways leading to its activation. Forskolin is known to directly stimulate adenylyl cyclase, which catalyzes the conversion of ATP to the second messenger cAMP. The rise in intracellular cAMP levels subsequently activates protein kinase A (PKA). Activated PKA then phosphorylates target proteins, including V1RD19, culminating in its activation. Similarly, IBMX acts as an inhibitor of phosphodiesterases, which normally break down cAMP. By preventing cAMP degradation, IBMX indirectly promotes the activation of PKA, leading to the phosphorylation and activation of V1RD19. Prostaglandin E2 (PGE2) operates through its interaction with EP receptors that also signal through adenylyl cyclase to increase cAMP and activate PKA, which is capable of phosphorylating and activating V1RD19.
Furthermore, histamine, through interaction with H2 receptors, and epinephrine, through beta-adrenergic receptors, both heighten cAMP levels and activate PKA, leading to the phosphorylation and subsequent activation of V1RD19. Isoproterenol acts similarly as a beta-adrenergic agonist to elevate cAMP and activate PKA, while adenosine, via A2A receptors, enhances cAMP levels, again leading to PKA activation. Another route of cGMP-mediated activation is exemplified by Vardenafil, which inhibits phosphodiesterase type 5, and sodium nitroprusside, which releases nitric oxide to stimulate guanylyl cyclase; both increase cGMP levels, activating protein kinase G (PKG), which can also phosphorylate and activate V1RD19. Anisomycin activates the JNK pathway, which includes kinases capable of phosphorylating a spectrum of proteins, and could include the activation of V1RD19. Angiotensin II engages with AT1 receptors to activate phospholipase C (PLC), leading to protein kinase C (PKC) activation, which is known to phosphorylate a wide range of proteins, potentially including V1RD19. Lastly, diacylglycerol serves as a direct activator of PKC, which then phosphorylates and activates V1RD19, demonstrating yet another mechanism by which this protein can be functionally activated through chemical means.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in cAMP levels, which activates PKA. PKA can then phosphorylate and activate V1RD19. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX inhibits phosphodiesterases, increasing cAMP and cGMP levels, thereby activating PKA and PKG, which may phosphorylate and activate V1RD19. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
PGE2 engages EP receptors, activating adenylyl cyclase and increasing cAMP, which activates PKA. PKA is known to phosphorylate and activate V1RD19. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Histamine, through H2 receptors, activates adenylyl cyclase, increasing cAMP and activating PKA, which could phosphorylate and activate V1RD19. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Epinephrine activates beta-adrenergic receptors, increasing cAMP and activating PKA, which can phosphorylate and activate V1RD19. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol activates beta-adrenergic receptors, increasing cAMP and activating PKA, which then phosphorylates and activates V1RD19. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $33.00 $47.00 $294.00 $561.00 $1020.00 $2550.00 $4590.00 | 1 | |
Adenosine activates A2A receptors leading to increased cAMP and activation of PKA, which in turn can phosphorylate and activate V1RD19. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $516.00 $720.00 $16326.00 | 7 | |
Vardenafil inhibits phosphodiesterase type 5, increasing cGMP levels and activating PKG, which can phosphorylate and activate V1RD19. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $42.00 $83.00 $155.00 | 7 | |
Sodium Nitroprusside releases NO, which stimulates guanylyl cyclase, increasing cGMP and activating PKG. PKG may phosphorylate and activate V1RD19. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin activates JNK, which is known to phosphorylate and activate various proteins, potentially including V1RD19. | ||||||